Quality Improvement Guidelines for Endovascular Treatment of Iliac Artery Occlusive Disease

Journal Article · Sat Mar 15 04:00:00 EDT 2008 · Cardiovascular and Interventional Radiology

DOI:https://doi.org/10.1007/S00270-007-9095-5· OSTI ID:21090645

Tsetis, Dimitrios ^[1]; Uberoi, Raman ^[2]

---

1. University Hospital of Heraklion, Medical School of Crete, Department of Radiology (Greece)
2. John Radcliffe Hospital, Department of Radiology (United Kingdom)

Endovascular therapy is the treatment of choice for type A and the preferred treatment for type B lesions. In selective patients, this type of treatment can be applied in type C and even type D lesions. Ipsilateral femoral, contralateral femoral, and brachial approach and both the intraluminal and subintimal space can be used for successful recanalization. The application of stents has improved the immediate hemodynamic and probably long-term clinical results of iliac percutaneous transluminal angioplasty. However, the superiority of primary or direct stenting over selective stenting has not been proven yet. The choice of stent type depends on lesion morphology and location but otherwise there is insufficient evidence to support the use of a particular stent design. There is insufficient evidence to justify routine use of covered stents. All patients should receive antiaggregant therapy following endovascular recanalization of iliac arteries. There is no consensus regarding prophylaxis with antibiotics in iliac recanalization procedures.

• OSTI ID: 21090645
• Journal Information: Cardiovascular and Interventional Radiology, Journal Name: Cardiovascular and Interventional Radiology Journal Issue: 2 Vol. 31; ISSN 0174-1551; ISSN CAIRDG
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIBIOTICS
ARTERIES
MORPHOLOGY
PATIENTS
PREVENTIVE MEDICINE
RECOMMENDATIONS
THERAPY
VASCULAR DISEASES